Category Archives: Transhuman News

DataIntelo has added a latest report on the Global Human Genetics Market that covers the 360 scope of the market and various parameters that are speculated to proliferate the growth of the market during the forecast period, 2021-2028. The market research report provides in-depth analysis in a structured and concise manner, which in turn, is expected to help the esteemed reader to understand the market exhaustively.

Major Players Covered In This Report:

QIAGENAgilent TechnologiesThermo Fisher ScientificIlluminaPromegaLabCorpGE

The research report confers information about latest and emerging market trends, key market drivers, restraints, and opportunities, supply & demand scenario, and potential future market developments that are estimated to change the future of the market. This report also serves the strategic market analysis, latest product developments, comprehensive analysis of regions, and competitive landscape of the market. Additionally, it discusses top-winning strategies that has helped industry players to expand their market share.

Get Exclusive Sample Report for Free @ https://dataintelo.com/request-sample/?reportId=155448

9 Key Report Highlights

Historical, Current, and Future Market Size and CAGR

Future Product Development Prospects

In-depth Analysis on Product Offerings

Product Pricing Factors & Trends

Import/Export Product Consumption

Impact of COVID-19 Pandemic

Changing Market Dynamics

Market Growth in Terms of Revenue Generation

Promising Market Segments

Impact of COVID-19 Pandemic On Human Genetics Market

The COVID-19 pandemic had persuaded state government bodies to impose stringent regulations on the opening of manufacturing facilities, corporate facilities, and public places. It had also imposed restrictions on travelling through all means. This led to the disruption in the global economy, which negatively impacted the businesses across the globe. However, the key players in the Human Genetics market created strategies to sustain the pandemic. Moreover, some of them created lucrative opportunities, which helped them to leverage their market position.

The dedicated team at DataIntelo closely monitored the market from the beginning of the pandemic. They conducted several interviews with industry experts and key management of the top companies to understand the future of the market amidst the trying times. The market research report includes strategies, challenges & threats, and new market avenues that companies implemented, faced, and discovered respectively in the pandemic.

On What Basis the Market Is Segmented in The Report?

The global Human Genetics market is fragmented on the basis of:

Products

CytogeneticsPrenatal GeneticsMolecular GeneticsSymptom Genetics

The drivers, restraints, and opportunities of the product segment are covered in the report. Product developments since 2017, products market share, CAGR, and profit margins are also included in this report. This segment confers information about the raw materials used for the manufacturing. Moreover, it includes potential product developments.

Applications

Research CenterHospitalForensic Laboratories

The market share of each application segment is included in this section. It provides information about the key drivers, restraints, and opportunities of the application segment. Furthermore, it confers details about the potential application of the products in the foreseeable future.

Regions

North America

Asia Pacific

Europe

Latin America

Middle East & Africa

Note: A country of choice can be included in the report. If more than one country needs to be added in the list, the research quote will vary accordingly.

The market research report provides in-depth analysis of the regional market growth to determine the potential worth of investment & opportunities in the coming years. This Human Genetics report is prepared after considering the social and economic factors of the country, while it has also included government regulations that can impact the market growth in the country/region. Moreover, it has served information on import & export analysis, trade regulations, and opportunities of new entrants in domestic market.

Buy the complete report @ https://dataintelo.com/checkout/?reportId=155448

7 Reasons to Buy This Report

Usage of Porters Five Force Analysis Model

Implementation of Robust Methodology

Inclusion of Verifiable Data from Respectable Sources

Market Report Can Be Customized

Quarterly Updates On Market Developments

Presence of Infographics, Flowcharts, And Graphs

Provides In-Depth Actionable Insights to Make Crucial Decisions

Ask for discount @ https://dataintelo.com/ask-for-discount/?reportId=155448

Below is the TOC of the report:

Executive Summary

Assumptions and Acronyms Used

Research Methodology

Human Genetics Market Overview

Global Human Genetics Market Analysis and Forecast by Type

Global Human Genetics Market Analysis and Forecast by Application

Global Human Genetics Market Analysis and Forecast by Sales Channel

Global Human Genetics Market Analysis and Forecast by Region

North America Human Genetics Market Analysis and Forecast

Latin America Human Genetics Market Analysis and Forecast

Europe Human Genetics Market Analysis and Forecast

Asia Pacific Human Genetics Market Analysis and Forecast

Asia Pacific Human Genetics Market Size and Volume Forecast by Application

Middle East & Africa Human Genetics Market Analysis and Forecast

Competition Landscape

If you have any doubt regarding the report, please connect with our analyst @ https://dataintelo.com/enquiry-before-buying/?reportId=155448

About DataIntelo

DataIntelo has extensive experience in the creation of tailored market research reports in several industry verticals. We cover in-depth market analysis which includes producing creative business strategies for the new entrants and the emerging players of the market. We take care that our every report goes through intensive primary, secondary research, interviews, and consumer surveys. Our company provides market threat analysis, market opportunity analysis, and deep insights into the current and market scenario.

To provide the utmost quality of the report, we invest in analysts that hold stellar experience in the business domain and have excellent analytical and communication skills. Our dedicated team goes through quarterly training which helps them to acknowledge the latest industry practices and to serve the clients with the foremost consumer experience.

Contact Info:

Name: Alex Mathews

Address: 500 East E Street, Ontario,

CA 91764, United States.

Phone No: USA: +1 909 414 1393

Email:[emailprotected]

Website:https://dataintelo.com

Go here to see the original:
Human Genetics Market 2021 Is Booming Across the Globe by Share, Size, Growth, Segments and Forecast to 2027 | Top Players Analysis- QIAGEN, Agilent...

NEW YORK Engagement strategies that welcome all research participants and enable the sharing of nuanced views could help medical institutions become viewed as more trustworthy, particularly among African Americans, a new study has found.

African Americans are underrepresented in genomics research, which in part stems from mistrust due to historical and continuing injustices in medical research and clinical care. To better understand how to best engage African-American research participants, researchers from the US National Human Genome Research Institute conducted focus groups of about four dozen African-American individuals who already had joined a genomics study to capture why they joined the study, how they wanted to be involved in the project, and their thoughts on which sequencing results from the study to return to participants.

As the researchers reported on Wednesday in the American Journal of Human Genetics, though some participants did harbor feelings of mistrust, most wanted to participate in research to contribute their views and represent their communities and further valued engagement approaches like focus groups that enable nuanced discussion of issues like return of results.

"Improving the engagement and recruitment of individuals from underrepresented groups to genomics research is critical," researchers led by NHGRI's Leslie Biesecker wrote in their paper. "Although there are historical and societal barriers that researchers cannot change, our findings highlight opportunities to implement policies that can improve on the trustworthiness of their institutions in the future."

The researchers invited 179 participants from the ClinSeq project to take part in one of six focus groups. All the contacted participants self-identified as African, African American, or Afro Caribbean. In all, 82 percent (49 participants) of those scheduled to attend the approximately 90-minute meetings did so. This high participation rate is consistent with previous findings that African-American individuals are willing to engage in research, the researchers noted.

In their discussion of motivations for joining ClinSeq, participants acknowledged there is mistrust of the medical field that could be a barrier to recruiting others to the study. Still, most participants said they joined the study to benefit their communities and improve the representation of African Americans in research, while others hoped for personal or family health benefits or joined out of curiosity.

The participants also noted that they were interested in being active partners or collaborators in the study and to help, for instance, with recruitment or describing study results to the community. They further often said that engagement activities should be offered to all participants and expressed preferences for approaches like focus groups that allow for nuanced discussions.

Within these focus groups, the researchers also asked the participants their thoughts on which research results were the most important to return. On individual worksheets, participants largely ranked life-threatening health implications as the most important to return, followed by ones that are preventable, treatable, or affect physical or mental health.

Discussions to develop a consensus ranking often centered on providing equal importance to conditions affecting physical and mental health and downplayed the need for ancestry-related results. The researchers noted that despite the importance given in individual rankings to the prioritization of preventable conditions, only two groups discussed it.

Still the findings suggested to the researchers that focus groups are an effective means of gathering participants' preferences for return of results and that discussions allowed participants to learn from one another and compromise to generate a consensus ranking.

"Given these benefits and the strong recommendations of our participants, we advocate for the use of modalities that allow as many participants as possible to express nuanced perspectives throughout the research process as a component of engaging African-American individuals in genomics research," the researchers wrote. "These approaches can be resource intensive and challenging to implement without changes to funding priorities but may be an important component of ensuring greater diversity in and engagement with study cohorts."

Originally posted here:
Study Reveals African Americans' Perspectives on Genomic Research Participation - GenomeWeb

Work type: Full-timeDepartment: Department of Paediatrics and Adolescent Medicine (21100)Categories: Academic-related Staff

Applications are invited for appointment as Post-doctoral Fellow in the Department of Paediatrics and Adolescent Medicine (Ref.: 503858), to commence as soon as possible for three years, with the possibility of renewal.

Applicants should have a Ph.D. degree and extended experience in immunology, molecular biology, human genetics or bioinformatics, with first-author publications in respected journals of the particular field. Those who are willing to explore new areas of study, including data analysis, are preferred. Applicants should be self-motivated, detail-oriented, and have excellent communication skills in English. .

The appointee will work on functionally characterizing the susceptibility genes for systemic lupus erythematosus (SLE; more information can be found in the recent publication in Nat Commun. 2021 Feb 3;12(1):772), using cutting-edge technologies in immunology, gene editing, transcriptomics, animal models, and integrative data analysis. Training opportunities in both genome-wide functional characterization and data analysis will be provided. There will also be chances to participate in research collaborations with international and Mainland collaborators. Enquiries about the duties of the post should be sent to Dr. Yang Wanling at yangwl@hku.hk.

A highly competitive salary commensurate with qualifications and experience will be offered, in addition to annual leave and medical benefits.

The University only accepts online applications for the above post. Applicants should apply online and upload an up-to-date C.V., a research statement and a study plan. References are only required for shortlisted candidates. Review of applications will start on May 7, 2021 and continue until October 31, 2021, or until the post is filled, whichever is earlier.

The rest is here:
Post-doctoral Fellow, Department of Paediatrics and Adolescent Medicine job with THE UNIVERSITY OF HONG KONG | 252578 - Times Higher Education (THE)

Scientists have discovered a new genetic disease, which causes some childrens brains to develop abnormally, resulting in delayed intellectual development and often early onset cataracts.

The majority of patients with the condition, which is so new it doesnt have a name yet, were also microcephalic, a birth defect where a babys head is smaller than expected when compared to babies of the same sex and age.

Researchers from the universities of Portsmouth and Southampton found that changes in a gene called coat protein complex 1 (COPB1) caused this rare genetic disease.

Now the variant has been identified, it will help clinicians come up with targeted interventions to help patients and their families, also opening the door to screening and prenatal diagnosis.

The research team, made up of frog geneticists, medical genomic research scientists and clinical geneticists, sequenced the DNA of affected patients and their family members, which identified COPB1 as the potential underlying cause of the disease. Using tadpoles to mimic the human gene variants, the tadpoles with the COPB1 gene changes had variably smaller brains than the control tadpoles and many of them had cataracts, just like the patients. This showed the link between the gene and disease very clearly.

Xenopus froglet finishing metamorphosis. Credit: Gretel Nicholson, EXRC

The findings are published in the journal Genome Medicine.

Study co-author Professor Matt Guille, who leads a laboratory in the Epigenetics and Developmental Biology research group at the University of Portsmouth, said: This is the first time that the tadpole has been used in such a direct way to help solve a clinical challenge.

In our initial experiments to test the link between a genetic variation and a disease we found to our surprise that by altering the DNA of tadpoles, four times out of five we could re-create the disease-related changes seen in human patients. This will allow us to support our colleagues in providing more timely, accurate diagnosis that patients and their families so desperately need.

Co-author Diana Baralle, Professor of Genomic medicine and a clinical geneticist at the University of Southampton, said: Next generation sequencing is transforming our ability to make new diagnoses and discover new causes for rare disorders. This story started with sisters I saw in clinic without a known underlying cause for their signs and symptoms. Looking closely at their genes, along with further functional molecular work and xenopus studies, we saw that this was a new previously undescribed syndrome. A diagnosis is so important to the family.

Transgenic Xenopus tadpoles. Credit: Dr Anna Noble, EXRC

One in 17 people will suffer from a rare disease at some time in their lives. Most of these rare diseases have a genetic cause and often affect children, but proving which gene change causes a disease is a huge challenge.

Professor Guille said that previously, while studies connecting a gene and a disease were mainly performed in mice; several labs, including his own at the University of Portsmouth, have recently shown that experiments in tadpoles can also provide very strong evidence about the function of variant human genes. The process of re-creating some gene variants in tadpoles is straightforward and can be done in as little as three days.

Professor Guille added: We now need to extend and improve our technology to make it applicable to the wider range of disease-related DNA changes provided to us by our clinical collaborators.

If the clinical researchers find the information sufficiently useful, then we will continue to work together to scale up the pipeline of gene function analysis so it can be used to direct effective interventions for a significant number of patients.

Reference: Biallelic variants in COPB1 cause a novel, severe intellectual disability syndrome with cataracts and variable microcephaly by William L. Macken, Annie Godwin, Gabrielle Wheway, Karen Stals, Liliya Nazlamova, Sian Ellard, Ahmed Alfares, Taghrid Aloraini, Lamia AlSubaie, Majid Alfadhel, Sulaiman Alajaji, Htoo A. Wai, Jay Self, Andrew G. L. Douglas, Alexander P. Kao, Matthew Guille and Diana Baralle, 25 February 2021, Genome Medicine.DOI: 10.1186/s13073-021-00850-w

Read more from the original source:
Strange New Genetic Disease Discovered That Causes Childrens Brains to Develop Abnormally - SciTechDaily

WORLD DNA Day is celebrated every year on April 25 to honour the achievement of the Human Genome Project (HGP), which was completed in April 2003, and the ground-breaking elucidation of the model structure of DNA double helix which was published in Nature magazine on April 25,1953. After the US Congress passed a resolution designating April 25 as DNA Day, the National Human Genome Research Institute began celebrating the day.

The HGP was an international project aimed at discovering the sequence of human DNA and defining all genes that are found in the human genome. The HGP played a big role in explaining the genetics of humans and helped us understand a variety of fundamental questions, including the total number of genes that we have, how our cells function, how diseases develop and what actually happens when we become sick.

The HGP improved biology and medicine because establishing the human genome sequence led to the designing of high-throughput sequencing technologies, and encouraged scientists, doctors and the community to discuss the ethical and social problems raised by such technologies.

Facts discovered about our DNA are quite amazing. For instance, siblings with the same mother and father, except identical twins, share 50% of their DNA. Uncle-nephew or aunt-nephew/niece share 25% of their DNA while cousins share 12.5%. When the HGP was completed, it was found that humans contain approximately 25,000 genes. These genes differ in size from a few hundred DNA bases to over two million bases. Each individual inherits two copies of each gene, one from each parent. Humans are 99.9% genetically similar and it is the 0.1% difference that makes each of us unique.

One of the biggest beneficiaries of the HGP is the field of medicine. Data from a patient's genetic profile may assist doctors in selecting the appropriate drug or treatment and administering it at the appropriate dose or regimen. This new approached in healthcare is called personalised or precision medicine. Every day, new genetic data is being profiled and used to improve the implementation of personalised medicine. As more DNA data is understood, personalised medicine may soon become routine and a part of mainstream medicine.

Besides blood, DNA can be extracted from skin, saliva, amniotic fluid and other tissues. These specimens can be studied in a genetic lab for variations in genes, DNA or proteins. Services for such genetic testing are now available online. Many companies are now offering direct to consumer genetic testing which offers the public genetic tests without having to go through a medical doctor.

Anyone can now order a genetic test by contacting these companies which will then send test kits that provide manuals and tools for extracting a saliva sample or a buccal smear that contains DNA in the comfort of their home. The specimen can then be delivered to a laboratory where the search for unique variations in genes or DNA is carried out.

While such direct to consumer genetic testing has helped many people to know more about their DNA, it must be understood that genetic data analysis is complicated and contextual reliant, and the results can yield false positive and false negative outcomes.

Anyone who is worried about the outcome of a direct to consumer genetic test should ask for guidance from a certified clinical geneticist or a genetic counsellor. The public should understand that these new technologies and approaches are intended to assist clinicians and they are not without their limitations and shortcomings.

Geneticists, health professionals, educators and the general public should join hands in the effort to study our DNA and appreciate current developments in genetic research that contribute to advances that affect our lives.

PROF ZILFALIL ALWI

Head, Malaysian Node of the Human Variome Project (MyHVP) & President, Malaysian Society of Human Genetics (MSHG)

Visit link:
Appreciating genetic research that affects our lives - The Star Online

The PCR technology, which requires cycles of extreme heating and cooling, can multiply small segments of DNA millions or even billions of times in a short period. It has proved crucial in many ways, including the identification of DNA at a crime scene and, more recently, detecting whether someone has the coronavirus.

PCR is fundamental to everything we do in molecular biology today, said Yuka Manabe, a professor of medicine in the division of infectious diseases at the Johns Hopkins University School of Medicine. Mullis couldnt have done PCR without a rock-stable enzyme.

April 27, 2021, 5:57 a.m. ET

Thomas Dale Brock was born on Sept. 10, 1926, in Cleveland. His father, Thomas, an engineer who ran the boiler room at a hospital, died when Tom was 15, pushing him and his mother, Helen (Ringwald) Brock, a nurse, into poverty. Tom, an only child, took jobs in stores to help her.

When he was a teenager, his interest in chemistry led him to set up a small laboratory with a friend in the loft of a barn behind his house in Chillicothe, Ohio, where he and his mother lived after his fathers death. The two friends experimented there with explosives and toxic gas.

After serving in the Navys electronics training program, Dr. Brock earned three degrees at Ohio State University: a bachelors in botany and a masters and a Ph.D. in mycology, the study of fungi.

With faculty jobs in short supply, Dr. Brock spent five years as a research microbiologist at the Upjohn Company before he was hired as an assistant professor of biology at Western Reserve University (now Case Western Reserve University) in Cleveland. After two years, he became a postdoctoral fellow in the universitys medical school. In 1960, he joined the department of bacteriology at Indiana University, Bloomington, where he taught medical microbiology.

Originally posted here:
Thomas Brock, Whose Discovery Paved the Way for PCR Tests, Dies at 94 - The New York Times

Polaris Market Research recently released a comprehensive report entitled Global Gaucher Disease Treatment Market, which focuses on providing a complete overview of the market. The report provides the latest information on all key aspects of the market and is expected to have a significant impact on market trends and performance during the forecast period. A key aspect is that the report is prepared in a way that will meet the needs of customers. This report is a complete guide for customers to make correct decisions based on business investment plans and strategies.

Research on the global Gaucher Disease Treatment market includes the avoidance framework in the Gaucher Disease Treatment market and the Gaucher Disease Treatment market share during the forecast period. The Gaucher Disease Treatment market report briefly discusses different key parameters such as market size, price, production cost, growth strategy, quantity, sales data, consumption rate and other basic parameters. The Gaucher Disease Treatment market report is divided into regions, product types, major manufacturers and applications.

Get More Details on this Report, Download Now( Sample PDF) : https://www.polarismarketresearch.com/industry-analysis/gaucher-disease-treatment-market/request-for-sample

With the assistance of different methods such as Porters Five Forces Analysis and SWOT Analysis, our researchers provide a clear outlook on current marketing trends and list the market participants that exist in the global Gaucher Disease Treatment market.

Manufacturers covered in this report are:

Acetelion Pharmaceutical (J&J Ltd.), Shire Human Genetics Therapies, Inc., Erad Therapeutic Inc., and JCR Pharmaceuticals Co Ltd.

Detailed analysis of the impact of the COVID-19 pandemic on businesses: Understanding the long-term and short-term impacts

Most companies are facing career-critical anxiety cases related to the coronavirus outbreak, and this situation is increasing, including the risk of economic recession, supply chain disruption, and possible decline in consumer spending. All these conditions will operate in different ways in different regions and industries, which will require more accurate and timely market research than ever before.

Market Segmentation:

Gaucher Disease Treatment Market Size and Forecast by Disease type, 2018 2025

Gaucher Disease Treatment Market Size and Forecast by Treatment type, 2018 2025

The main focus of this research report on the market for Gaucher Disease Treatment is providing study of following key points:

Get Exclusive Discount @ https://www.polarismarketresearch.com/industry-analysis/gaucher-disease-treatment-market/request-for-discount-pricing

Regional Analysis:

The report provides information about the market area, which is further subdivided into sub-regions and countries. In addition to market share in each country and subregion, this chapter of this report also provides information on profit opportunities. This chapter of the report mentions the share and market growth rate of each region, country, and sub-region in the estimated time period.

The research provides reliable answers to several key questions, such as:

In short, the Gaucher Disease Treatment Market report is the true source of access to research data that is expected to double your business. The report provides information such as economic scenarios, earnings, constraints, trends, market growth rates and figures.

If You Have Any Query, Ask Our Experts @ https://www.polarismarketresearch.com/industry-analysis/gaucher-disease-treatment-market/speak-to-analyst

About Polaris market Research

Polaris market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across industry verticals.

Contact Us

Corporate Sales, USA

Polaris market Research

Phone: 1-646-568-9980

Email:sales@polarismarketresearch.com

Web:www.polarismarketresearch.com

Go here to see the original:
Gaucher Disease Treatment Market 2021 | Size, Growth, Key Players, Supply Chain And Forecast : Acetelion Pharmaceutical (J&J Ltd.) Shire Human...

Soil Biochemist Asmeret Berhe Picked to Lead DOE Science Office

As part of a set of nominees announced last week, President Biden named Asmeret Berhe as his pick to lead the Department of Energys Office of Science. The office oversees a fleet of scientific user facilities and 10 of DOEs 17 national labs, and with a $7 billion budget, it is the federal governments largest funder of fundamental research in the physical sciences. Berhe currently is a biogeochemist at the University of California, Merced, specializing in how organic matter in the soil responds to climate change and other environmental perturbations. Originally from Eritrea in East Africa, she earned a bachelors degree from the University of Asmara in 1996 and a doctorate from the University of California, Berkeley in 2006, and she has been on the faculty at UC Merced since 2009. Berhes expertise accords with the Biden administrations focus on climate change, and she has been a frequent user of Pacific Northwest National Labs Environmental Molecular Sciences Lab, which is supported by the Office of Sciences Biological and Environmental Research program. She is also a proponent of increasing diversity and equity in STEM and is a key player in the ADVANCEGeo Partnership, a National Science Foundation-funded effort to combat sexual harassment and other issues affecting workplace climate in the geosciences. Biden has not yet named a nominee to be under secretary for science and energy, a position that oversees the Office of Science and DOEs applied energy R&D programs. For up-to-date information on nominations to key science positions, consult FYIs Federal Science Leadership Tracker.

President Biden also announced he is nominating oceanographer Richard Spinrad to lead the National Oceanic and Atmospheric Administration. Spinrad is currently a professor at Oregon State University and has held several roles at NOAA over the last two decades, serving as its chief scientist and as head of the Office of Oceanic and Atmospheric Research and National Ocean Service. While at NOAA, Spinrad co-chaired the White House committee that developed the nations first decadal ocean research strategy and worked to advance NOAAs proposal to establish a National Climate Service. Prior to joining NOAA, Spinrad served in leadership positions in research and oceanography offices within the U.S. Navy.

Several other nominations for research-related roles were also announced last week:

The National Academies announced last week that University of Florida biologist Robert Ferl and MIT materials scientist Krystyn Van Vliet will co-chair the next decadal survey on biological and physical sciences research in space. The survey will suggest priorities for NASAs program that supports research projects in spaceflight environments, such as aboard the International Space Station. Responsibility for the program was transferred from the agencys human exploration directorate to its science directorate in 2020. In addition to identifying emerging research frontiers, the survey will consider topics such as potential research campaigns, the role of commercially operated space platforms, opportunities for collaboration with international partners, and the limited lifetime of the ISS. The study is expected to be completed in 2023.

At the White Houses climate leadership summit last week, President Biden announced that by 2030 the U.S. will halve its greenhouse gas emissions from 2005 levels, in an effort to set higher expectations ahead of the United Nations climate conference later this year. Presidential Climate Envoy John Kerry called the goal ambitious but appropriate and achievable, saying that meeting it will require new technologies in areas such as battery storage and carbon capture systems. To that end, the White House Council of Economic Advisors released a report last week outlining actions the U.S. could take to accelerate energy innovation and encourage greater private-sector R&D investment. Senior administration officials also announced new multinational initiatives, including a forum with several other oil and gas-producing nations to develop pragmatic net-zero emission strategies, and an agreement with India to speed up clean energy deployment.

At a House Science Committee hearing last week, lawmakers discussed the prospects of creating a climate service to facilitate access to climate information from across the federal government. Environment Subcommittee Chair Mikie Sherrill (D-NJ) highlighted the potential for growing inequities in access to climate and weather data if the private sector takes too large a role, saying that not all communities can hire consultants or a climate services firm to help them incorporate climate risk into their resilience planning. Pointing to two bills she has sponsored aimed at improving understanding of flood risks, she said they are just one piece of the puzzle when it comes to improving authoritative and actionable federal tools and technical assistance for climate adaptation. While Committee Ranking Member Frank Lucas (R-OK) has stressed the need for climate information in areas such as agriculture, he and Subcommittee Ranking Member Stephanie Bice (R-OK) questioned whether a dedicated service is necessary. Lucas argued the National Oceanic and Atmospheric Administration already serves that function and that establishing a new duplicative service only serves to create more red tape and hurdles to our budding weather industry.

At a meeting last week, the Senate Foreign Relations Committee approved bipartisan legislation aimed at better positioning the U.S. to compete with China. It includes a provision empowering the Committee on Foreign Investment in the United States (CFIUS) to block universities from accepting certain foreign gifts and contracts, including ones worth more than $1 million that relate to critical technologies. Committee Ranking Member Jim Risch (R-ID) has said the provision is his top priority, citing a desire to help prevent the Chinese government from exerting influence on universities and to address risks of intellectual property theft. A group of university associations wrote to the committee before the meeting to oppose the provision, stating it would require expensive and time-consuming reviews of a wide range of university gifts and contracts against unknown and ill-defined criteria by an agency not designed or equipped to carry out this task. They also argued that uncertainty created by what might be blocked by CFIUS reviews will be a significant disincentive for philanthropic giving, undercutting U.S. competitiveness. American Council on Education President Ted Mitchell told Bloomberg that granting such a denial authority over research projects not funded by the federal government would be unprecedented. His organization has estimated that about 700 gifts and contracts that were reported to the Department of Education in 2019 could be subject to review under the proposal. To address some of these concerns, the committee adjusted the provision to require CFIUS to consider input from science agencies. The bill now heads to the Senate floor, where it could be bundled with the Endless Frontier Act.

At a Senate hearing last week, the National Institutes of Health provided updated statistics on its investigation of scientists for policy violations such as failing to disclose substantial employment ties with foreign entities, mainly in China. NIH extramural research head Mike Lauer told the committee the agency has identified more than 500 scientists of concern to date and that more than 100 have been removed from the NIH ecosystem through a variety of ways resignations, terminations, premature retirements, internal debarments. He emphasized that the violators represent only a small fraction of NIH grantees and remarked, We remain conscious of how these [enforcement] actions could affect the morale of honest and dedicated foreign researchers, particularly in the context of a pandemic that has exacerbated acts of discrimination and harassment against Asian Americans. The vast majority of Chinese scientists working in America are committed to the cause of expanding knowledge for the betterment of humankind, and to do so in a fair and honest way. We must say this at every opportunity. Senators generally did not question NIHs investigative approach to date, though Health Committee Ranking Member Richard Burr (R-NC) expressed concern that no one entity is responsible for identifying cases in which scientists have falsified information or violated rules.

Last week, the National Academies released a report from a study evaluating the U.S. research enterprises ability to monitor and help prevent the international proliferation of nuclear weapons and fissile material. Congress mandated the study and set a short deadline for it after deeming updates the National Nuclear Security Administration submitted on the subject to be unsatisfactory. However, because of disruptions caused by the COVID-19 pandemic, the Academies divided the study into two phases. The new report conveys findings from the first phase, which covers work the committee was able to undertake immediately. It offers 16 recommendations, including formalizing interagency coordination of nonproliferation efforts, expanding NNSAs testbed infrastructure and nuclear nonproliferation stewardship program, and bolstering the agencys technology transition activities. The report notes such efforts would require additional funding, but defers discussion of specific amounts to the studys second phase. The studys chair to date, former Sandia National Labs Director Jill Hruby, was recently nominated by President Biden to lead NNSA.

Leaders from the Defense Advanced Research Projects Agency and the R&D arms of the three military departments updated the Senate Armed Services Committee last week on recent efforts to increase innovation capabilities. Among the programs they spotlighted were Army Futures Commands Team Ignite, the Navys NavalX, and the Air Force Research Labs Transformational Capabilities Office and Vanguard programs, all of which aim to facilitate R&D collaborations and spur technology projects that respond to pressing military needs. The witnesses also pointed to exercises such as the Armys soldier touch points and Project Convergence and the Navys Integrated Battle Problem 21, which concludes this week, as key examples of efforts to integrate the development of technology and military tactics.

Lawmakers introduced a variety of science-focused bills in recent weeks, including ones focused on the STEM workforce, research security, quantum information science, energy research, manufacturing, and weather and climate forecasting:

More:
The Week of April 26, 2021 - FYI - FYI: Science Policy News